Iprolone, created in 2009 (Germany), from 293 sister brands and 4958 competing brands. The Iprolone brand is owned by TEVA PHARMACEUTICALS INDUSTRIES LIMITED, a company listed in New York. Iprolone belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
TEVA PHARMACEUTICALS INDUSTRIES LIMITED
(Iprolone)
over 5 years*
USD 12.52